James Bramwell - Avantor President
| AVTR Stock | USD 21.06 0.02 0.1% |
President
Mr. James Bramwell is Executive Vice President Strategic Partners of the Company. In his current role, Mr. Bramwell leads our customer relationships and contracts globally. Prior to assuming his current position, Mr. Bramwell served as VWRs Senior Vice President, Strategic Partners, a position he held from June 2008 to November 2017. Prior to this role, Mr. Bramwell served in several roles at VWR including Area Vice President of the Southwest U.S. and Mexico and Vice President of Major Accounts. Mr. Bramwell also served as the President of the VWR Foundation for four years since 2017.
| Age | 57 |
| Tenure | 7 years |
| Address | Radnor Corporate Center, Radnor, PA, United States, 19087 |
| Phone | 610 386 1700 |
| Web | https://www.avantorsciences.com |
Latest Insider Transactions
Bramwell earned a B.S. in business management from Brigham Young University.Avantor Management Efficiency
The company has return on total asset (ROA) of 0.0327 % which means that it generated a profit of $0.0327 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0581 %, meaning that it created $0.0581 on every $100 dollars invested by stockholders. Avantor's management efficiency ratios could be used to measure how well Avantor manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Avantor's Return On Tangible Assets are relatively stable compared to the past year. As of 11/30/2024, Return On Assets is likely to grow to 0.03, while Return On Capital Employed is likely to drop 0.04. At this time, Avantor's Intangible Assets are relatively stable compared to the past year. As of 11/30/2024, Non Currrent Assets Other is likely to grow to about 206.1 M, while Net Tangible Assets are likely to drop (4.7 B).Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Steve Morris | Sensient Technologies | 60 | |
| Andrew Jones | Minerals Technologies | 61 | |
| Sean Lannon | Axalta Coating Systems | 45 | |
| Brain Berube | Axalta Coating Systems | 57 | |
| Theodore Clark | H B Fuller | 70 | |
| Carey Dorman | Element Solutions | 34 | |
| Erica McLaughlin | Cabot | 47 | |
| Zhiwei Cai | H B Fuller | 61 | |
| David Slinkman | Quaker Chemical | 59 | |
| David Jones | Innospec | 55 | |
| Yvonne Mohrenfels | Ashland Global Holdings | 58 | |
| Traci Jensen | H B Fuller | 57 | |
| M Malik | H B Fuller | 53 | |
| Scot Benson | Element Solutions | 58 | |
| Hobart Kalkstein | Cabot | 54 | |
| Vinod Purayath | Avient Corp | 45 | |
| Daniel Monagle | Minerals Technologies | 58 | |
| Jessica Moskowitz | Oil Dri | 41 | |
| Thomas Meek | Minerals Technologies | 67 | |
| Wilbert Platzer | Quaker Chemical | 63 | |
| Paula Cooney | H B Fuller | 50 | |
Management Performance
| Return On Equity | 0.0581 | ||||
| Return On Asset | 0.0327 |
Avantor Leadership Team
Elected by the shareholders, the Avantor's board of directors comprises two types of representatives: Avantor inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avantor. The board's role is to monitor Avantor's management team and ensure that shareholders' interests are well served. Avantor's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avantor's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan Peacock, Lead Independent Director | ||
| Joseph Massaro, Independent Director | ||
| Christophe MBA, Executive AMEA | ||
| Lan Kang, Independent Director | ||
| Tanya Foxe, Executive Vice President - Global Operations and Supply Chain | ||
| Thomas Szlosek, Chief Financial Officer, Executive Vice President | ||
| Matthew Holt, Independent Director | ||
| Brittany Hankamer, Executive Officer | ||
| Brent Jones, Executive CFO | ||
| Mala Murthy, Independent Director | ||
| Mark Murray, Executive Vice President of the Biomaterials and Advanced Technologies Platform | ||
| John Carethers, Independent Director | ||
| Steven Eck, Senior Vice President Chief Accounting Officer | ||
| Juan Andres, Independent Director | ||
| James Bramwell, Executive Vice President, Avantor Services, Strategic Partners | ||
| Randy Stone, Executive Solutions | ||
| Christi Shaw, Independent Director | ||
| Benoit Gourdier, Executive Production | ||
| Sven Henrichwark, Executive Vice President of APAC | ||
| Allison Hosak, Senior Brand | ||
| Tommy CPA, Vice Relations | ||
| Sheri Lewis, Executive Vice President Global Operations and Supply Chain | ||
| Christina Jones, Vice Relations | ||
| Gerard Brophy, Executive Vice President - Biopharma Production | ||
| Rakesh Sachdev, Independent Director | ||
| Devashish Ohri, Executive Vice President - AMEA | ||
| Kitty Sahin, Executive Development | ||
| Michael Wondrasch, Executive Vice President, Chief Information Officer | ||
| Gregory Summe, Independent Director | ||
| Andre Moura, Director | ||
| Tommy Thomas, Vice President – Investor Relations | ||
| Frederic Vanderhaegen, Executive Vice President - Americas and Europe | ||
| Justin Esq, Gen VP | ||
| Claudius Sokenu, Corporate VP | ||
| Meghan Henson, Chief Human Resource Officer, Executive Vice President | ||
| Justin Miller, Executive Vice President General Counsel, Secretary | ||
| Rajiv Gupta, Non-Executive Chairman of the Board | ||
| Eric McAllister, Chief Human Resource Officer, Executive Vice President | ||
| Jo Natauri, Director | ||
| Michael Stubblefield, President, Chief Executive Officer, Director | ||
| Michael Severino, Independent Director | ||
| Christophe Couturier, Executive Vice President - Services, Strategy and Business Transformation |
Avantor Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avantor a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0581 | ||||
| Return On Asset | 0.0327 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 18.97 B | ||||
| Shares Outstanding | 680.61 M | ||||
| Shares Owned By Insiders | 1.20 % | ||||
| Shares Owned By Institutions | 98.80 % | ||||
| Number Of Shares Shorted | 31.9 M | ||||
| Price To Earning | 72.98 X |
Pair Trading with Avantor
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avantor position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avantor will appreciate offsetting losses from the drop in the long position's value.Moving together with Avantor Stock
| 0.68 | A | Agilent Technologies Sell-off Trend | PairCorr |
| 0.92 | ME | 23Andme Holding Upward Rally | PairCorr |
| 0.77 | VALN | Valneva SE ADR | PairCorr |
Moving against Avantor Stock
| 0.79 | DRUG | Bright Minds Biosciences Trending | PairCorr |
| 0.73 | VCYT | Veracyte | PairCorr |
| 0.67 | VERA | Vera Therapeutics | PairCorr |
| 0.64 | VCEL | Vericel Corp Ord | PairCorr |
| 0.6 | VANI | Vivani Medical | PairCorr |
The ability to find closely correlated positions to Avantor could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avantor when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avantor - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avantor to buy it.
The correlation of Avantor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avantor moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avantor moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avantor can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Avantor Stock Analysis
When running Avantor's price analysis, check to measure Avantor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avantor is operating at the current time. Most of Avantor's value examination focuses on studying past and present price action to predict the probability of Avantor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avantor's price. Additionally, you may evaluate how the addition of Avantor to your portfolios can decrease your overall portfolio volatility.